Beacon Harbor Wealth Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.56M Sell
24,323
-293
-1% -$104K 1.79% 19
2025
Q4
$8.06M Buy
24,616
+44
+0.2% +$14K 1.79% 20
2025
Q3
$6.93M Buy
24,572
+154
+0.6% +$44.7K 1.62% 22
2025
Q2
$6.82M Sell
24,418
-2,484
-9% -$704K 1.7% 23
2025
Q1
$8.38M Buy
26,902
+13,354
+99% +$3.94M 1.95% 14
2024
Q4
$3.53M Buy
+13,548
New +$4.02M 0.82% 44
2024
Q1
Sell
-12,993
Closed -$3.74M 70
2023
Q4
$3.74M Sell
12,993
-910
-7% -$248K 1.09% 40
2023
Q3
$3.74M Sell
13,903
-8,345
-38% -$2.08M 1.24% 43
2023
Q2
$4.94M Buy
22,248
+1,232
+6% +$286K 1.62% 30
2023
Q1
$5.08M Sell
21,016
-170
-0.8% -$41.7K 1.77% 29
2022
Q4
$5.56M Buy
+21,186
New +$5.68M 1.89% 20
2022
Q2
$5.89M Sell
24,200
-240
-1% -$58.8K 2.07% 17
2022
Q1
$5.91M Buy
+24,440
New +$5.62M 1.93% 17

Other funds holding AMGN

Beacon Harbor Wealth Advisors's AMGN Position: Q1 2026 in Review

Beacon Harbor Wealth Advisors reduced its Amgen (AMGN) stake by 1.2% in Q1 2026, selling an estimated $104K and leaving 24,323 shares worth $8.56M. The position accounts for 1.79% of the portfolio, ranked #19.

Beacon Harbor Wealth Advisors first reported a position in AMGN in Q1 2022 and has held it in 13 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Beacon Harbor Wealth Advisors held 24,323 shares of Amgen worth $8.56M as of Q1 2026.
  • Beacon Harbor Wealth Advisors sold 293 Amgen shares in Q1 2026, an estimated $104K.
  • Amgen made up 1.79% of Beacon Harbor Wealth Advisors's portfolio in Q1 2026, its #19 holding.
  • Beacon Harbor Wealth Advisors first reported a position in Amgen in Q1 2022 and has held it in 13 quarters since.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Beacon Harbor Wealth Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.